معرفی
Dr. Mark Salji is a Senior Clinical Lecturer at the School of Cancer Sciences, University of Glasgow, focusing on urological cancers, particularly prostate cancer. His work bridges clinical and laboratory research, emphasizing treatment resistance, metabolic reprogramming, and diagnostic advancements.
His recent publications analyze:
- Prostate cancer staging post-surgery (2023)
- Lipid metabolism in castration-resistant models (2022)
- Palladium-activated chemotherapy (2022)
- Murine model metabolic pathways (2022)
- Treatment-resistant lipid reprogramming (2022)
- Predictive radiological biomarkers (2018)
Grants from the Prostate Cancer Foundation (2023–2026) and The Urology Foundation (2024–2025) support his work on PSMA metabolites and N-acetyl aspartate in prostate cancer.
۰مقاله منتشرشده
